NO990706D0 - Behandling av allergiske responser i °vre luftveier med en kombinasjon av histaminreseptorantagonister - Google Patents

Behandling av allergiske responser i °vre luftveier med en kombinasjon av histaminreseptorantagonister

Info

Publication number
NO990706D0
NO990706D0 NO990706A NO990706A NO990706D0 NO 990706 D0 NO990706 D0 NO 990706D0 NO 990706 A NO990706 A NO 990706A NO 990706 A NO990706 A NO 990706A NO 990706 D0 NO990706 D0 NO 990706D0
Authority
NO
Norway
Prior art keywords
treatment
combination
receptor antagonists
respiratory tract
histamine receptor
Prior art date
Application number
NO990706A
Other languages
English (en)
Norwegian (no)
Other versions
NO990706L (no
Inventor
William Kreutner
John A Hey
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO990706L publication Critical patent/NO990706L/no
Publication of NO990706D0 publication Critical patent/NO990706D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO990706A 1996-08-16 1999-02-15 Behandling av allergiske responser i °vre luftveier med en kombinasjon av histaminreseptorantagonister NO990706D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68995196A 1996-08-16 1996-08-16
PCT/US1997/013903 WO1998006394A1 (en) 1996-08-16 1997-08-13 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists

Publications (2)

Publication Number Publication Date
NO990706L NO990706L (no) 1999-02-15
NO990706D0 true NO990706D0 (no) 1999-02-15

Family

ID=24770500

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990706A NO990706D0 (no) 1996-08-16 1999-02-15 Behandling av allergiske responser i °vre luftveier med en kombinasjon av histaminreseptorantagonister

Country Status (25)

Country Link
EP (1) EP0920315B1 (cs)
JP (2) JP3638289B2 (cs)
KR (1) KR20000029975A (cs)
CN (1) CN1152682C (cs)
AR (1) AR008293A1 (cs)
AT (1) ATE314071T1 (cs)
AU (1) AU722040B2 (cs)
BR (1) BR9711149A (cs)
CA (1) CA2263163A1 (cs)
CO (1) CO4910138A1 (cs)
CZ (1) CZ43299A3 (cs)
DE (1) DE69734984D1 (cs)
HU (1) HUP9904362A3 (cs)
ID (1) ID17871A (cs)
IL (1) IL128573A0 (cs)
MY (1) MY116130A (cs)
NO (1) NO990706D0 (cs)
NZ (1) NZ334063A (cs)
PE (1) PE100298A1 (cs)
PL (1) PL191073B1 (cs)
SK (1) SK20099A3 (cs)
TR (1) TR199900326T2 (cs)
TW (2) TWI221768B (cs)
WO (1) WO1998006394A1 (cs)
ZA (1) ZA977263B (cs)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2214245C2 (ru) * 1997-03-26 2003-10-20 Сепракор Инк. Химически- и термостабильные готовые формы норастемизола
JP4344405B2 (ja) * 1997-08-26 2009-10-14 アベンティス・ファーマスーティカルズ・インコーポレイテッド ピペリジノアルカノール−鬱血除去剤の組合せ用医薬組成物
US5990147A (en) * 1997-11-07 1999-11-23 Schering Corporation H3 receptor ligands of the phenyl-alkyl-imidazoles type
US6034251A (en) * 1997-11-07 2000-03-07 Schering Corporation Phenyl-alkyl-imidazoles
EP1028948B1 (en) * 1997-11-07 2003-01-29 Schering Corporation Phenyl-alkyl-imidazoles as h3 receptor antagonists
EP1028956A1 (en) * 1997-11-07 2000-08-23 Schering Corporation Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
IL135729A0 (en) * 1997-11-07 2001-05-20 Schering Corp H3 receptor ligands of the phenyl-alkyl-imidazoles type
US6384038B1 (en) * 1998-04-14 2002-05-07 Sepracor Inc. Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
JP2002527381A (ja) * 1998-10-09 2002-08-27 シェーリング コーポレイション アレルギー性疾患を処置するための組成物および方法
US6100279A (en) * 1998-11-05 2000-08-08 Schering Corporation Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
CA2383214A1 (en) * 1999-09-22 2001-03-29 Schering Corporation Treating allergic and inflammatory conditions
HK1046367A1 (zh) 2000-02-03 2003-01-10 Schering Corporation 治疗过敏和炎症症状
PE20020507A1 (es) 2000-10-17 2002-06-25 Schering Corp Compuestos no-imidazoles como antagonistas del receptor histamina h3
GB2373186A (en) * 2001-02-23 2002-09-18 Astrazeneca Ab Pharmaceutical combinations of a CCR3 antagonist and a compound which is usefulreatment of asthma, allergic disease or inflammation
MXPA03008356A (es) 2001-03-13 2003-12-11 Schering Corp Compuestos del tipo no imidazol como antagonistas de histamina h3.
US7105505B2 (en) 2002-04-18 2006-09-12 Schering Corporation Benzimidazole derivatives useful as histamine H3 antagonists
US7220735B2 (en) 2002-04-18 2007-05-22 Schering Corporation Benzimidazolone histamine H3 antagonists
IL165863A0 (en) 2002-06-24 2006-01-15 Schering Corp Indole derivatives useful as histamine H3 antagonists
WO2004066960A2 (en) * 2003-01-28 2004-08-12 Schering Corporation Combination of h1, h3 and h4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
TW200738676A (en) 2005-06-20 2007-10-16 Schering Corp Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists
EP2318388A2 (en) 2008-07-23 2011-05-11 Schering Corporation Tricyclic spirocycle derivatives and methods of use thereof
AU2009303444A1 (en) 2008-10-16 2010-04-22 Schering Corporation Azine derivatives and methods of use thereof
US20110245267A1 (en) 2008-12-19 2011-10-06 Schering Plough Corporation Piperidine and piperazine derivatives and methods of use thereof
WO2010071819A1 (en) 2008-12-19 2010-06-24 Schering Corporation Bicyclic heterocyclic derivatives and methods of use thereof
EP2408453B1 (en) 2009-03-17 2022-01-05 Nicox Ophthalmics, Inc. Ophthalmic formulations of cetirizine and methods of use
US8569273B2 (en) 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
US9399032B2 (en) * 2009-05-14 2016-07-26 The General Hospital Corporation Methods and compositions for treating degenerative and ischemic disorders
US8759357B2 (en) 2009-10-08 2014-06-24 Merck Sharp & Dohme Corp. Inhibitors of fatty acid binding protein (FABP)
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
RU2685277C1 (ru) * 2018-05-24 2019-04-17 Общество с ограниченной ответственностью "Фарминтерпрайсез Аллерджи" Применение бисамидного производного малоновой кислоты для лечения аллергических и других заболеваний человека и животных

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201683B (en) * 1987-08-04 1990-12-28 Biogal Gyogyszergyar Process for producing pharmaceutical compositions for promoting healing of wounds
US5019591A (en) * 1989-02-17 1991-05-28 Pennsylvania Research Corporation Method for treating retinopathy and other small vessel disorders associated with diabetes
GB9303210D0 (en) * 1993-02-17 1993-03-31 Univ Manitoba Cancer treatment

Also Published As

Publication number Publication date
SK20099A3 (en) 2000-08-14
JP3638289B2 (ja) 2005-04-13
NZ334063A (en) 2000-09-29
JP2003095979A (ja) 2003-04-03
TR199900326T2 (xx) 1999-05-21
PL331617A1 (en) 1999-08-02
CN1233179A (zh) 1999-10-27
CA2263163A1 (en) 1998-02-19
NO990706L (no) 1999-02-15
ATE314071T1 (de) 2006-01-15
HUP9904362A3 (en) 2000-12-28
HUP9904362A2 (hu) 2000-11-28
CO4910138A1 (es) 2000-04-24
BR9711149A (pt) 1999-08-17
ID17871A (id) 1998-02-05
CN1152682C (zh) 2004-06-09
MY116130A (en) 2003-11-28
AR008293A1 (es) 1999-12-29
PE100298A1 (es) 1999-01-11
DE69734984D1 (de) 2006-02-02
IL128573A0 (en) 2000-01-31
AU722040B2 (en) 2000-07-20
EP0920315B1 (en) 2005-12-28
JP2000505094A (ja) 2000-04-25
TW200427450A (en) 2004-12-16
AU3973397A (en) 1998-03-06
ZA977263B (en) 1998-02-16
PL191073B1 (pl) 2006-03-31
WO1998006394A1 (en) 1998-02-19
TWI221768B (en) 2004-10-11
EP0920315A1 (en) 1999-06-09
CZ43299A3 (cs) 1999-07-14
KR20000029975A (ko) 2000-05-25

Similar Documents

Publication Publication Date Title
NO990706L (no) Behandling av allergiske responser i °vre luftveier med en kombinasjon av histaminreseptorantagonister
EE200100372A (et) TWEAK-valgu ja TWEAK-valgu retseptori antagonistid ja nende kasutamine immuunhaiguste raviks
FI20002103L (fi) Amidijohdannaisia ja nosiseptiiniantagonisteja
DE69509765D1 (de) N-heterocyclyl sulphonamid-derivate und ihre verwendung als endothelin-antagonisten
PT832082E (pt) Derivados de n-heteroaril-piridinossulfonamidas e sua utilizacao como antagonistas de endotelina
BR9706968A (pt) Uso de antagonistas de alfa-ppar e gama-ppar para o tratamento de sindrome x
FI973446L (fi) Bentsyylipiperidiinit ja piperatsiinit muskariiniantagonisteina
FI946005L (fi) Glysiinireseptoriantagonisteja ja niiden käyttö
DE69932265D1 (de) Musikaktionsspielsystem und computerlesbare Aufzeichnungsvorrichtung
DK0984773T3 (da) Farmaceutisk formulering med omeprazol
DE69515891T8 (de) Verbundstoff und saugfähiges Kleidungsstück mit diesem Verbundstoff
FI973419A7 (fi) Epäorgaanisten aerogeelien käyttö lääkkeiden valmistuksessa
IS5113A (is) Notkun antagónista CB1-viðtaka til meðhöndlunar löngunartruflana
EE200000778A (et) 4-bensüülpiperidiinalküülsulfoksiidi heterotsüklid ja nende kasutamine NMDA retseptori alaliikide suhtes selektiivsete antagonistidena
FI961270A7 (fi) Takykiniinien antagonisteja ja 3-(5-tetratsolyyli-bentsyyli)amino-piperidiinijohdannaisia
EE9900003A (et) Meetod ja seade anduri fikseerimiseks kehasiseses luumenis
FI964078A0 (fi) Ultraäänen käyttö paperinvalmistuksen yhteydessä
EE04431B1 (et) Bensamidiini derivaadid ja nende kasutamine LTB-4antagonistliku mõjuga ravimitena
ATE227724T1 (de) Muscarinagonisten und antagonisten
NO994321D0 (no) Absorberende gjenstand med "pustende" ytre lag
PT946175E (pt) Utilizacao de uma combinacao de inibidores de h+, k+ -atpase e de glucocorticiodes no tratamento de polipos nasais
NO983871D0 (no) Oksa- og tiadiazol muskarinreseptorantagonister
IL131127A0 (en) 2-Amino substituted pyridines for use in the treatment of arteriosclerosis and hyperlipoproteinaemia
NO962806D0 (no) Absorberende gjenstand med innböyde barrieremansjetter
EP0747055A3 (en) Use of tachykinin receptor antagonists to treat the common cold and allergic rhinitis